COVID-19 had a mild clinical course in patients with Agammaglobulinemia lacking B lymphocytes, whereas it developed aggressively in Common Variable Immune Deficiency. Our data offer mechanisms for possible therapeutic targets.
A possible role for B cells in COVID-19?: Lesson from patients with Agammaglobulinemia
Cinetto, Francesco
Investigation
;Agostini, Carlo
Writing – Original Draft Preparation
;
2020
Abstract
COVID-19 had a mild clinical course in patients with Agammaglobulinemia lacking B lymphocytes, whereas it developed aggressively in Common Variable Immune Deficiency. Our data offer mechanisms for possible therapeutic targets.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
main.pdf
accesso aperto
Tipologia:
Published (publisher's version)
Licenza:
Accesso gratuito
Dimensione
684.63 kB
Formato
Adobe PDF
|
684.63 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
